Compounds > lapatinib
Page last updated: 2024-09-05

lapatinib and milrinone

lapatinib has been researched along with milrinone in 1 studies

Compound Research Comparison

Studies
(lapatinib)		Trials
(lapatinib)		Recent Studies (post-2010)
(lapatinib)		Studies
(milrinone)		Trials
(milrinone)		Recent Studies (post-2010) (milrinone)
1,9193051,4421,605235452

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)milrinone (IC50)
Phosphodiesterase Bos taurus (cattle)1
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.3
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8AHomo sapiens (human)0.3
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.52
Prostaglandin G/H synthase 1Homo sapiens (human)4.7
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)6
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)6
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)6
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)3.15
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)1.8674
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)1.8177
cGMP-specific 3',5'-cyclic phosphodiesteraseBos taurus (cattle)5
Phosphodiesterase Sus scrofa (pig)0.843

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for lapatinib and milrinone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016